USE OF AGLYCON PROTOPANAXATRIOL IN CANCER THERAPY

Details for Australian Patent Application No. 2003287833 (hide)

Owner PANAGIN PHARMACEUTICALS INC.

Inventors HUANG, Dong

Pub. Number AU-A-2003287833

PCT Number PCT/CA2003/0019

PCT Pub. Number WO2004/056371

Priority 60/434,441 19.12.02 US

Filing date 19 December 2003

Wipo publication date 14 July 2004

International Classifications

A61K 031/575 - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 031/655 - Azo (NN), diazo (N), azoxy (NON or N(O)N), azido (N) or diazoamino (NNN) compounds

A61K 031/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 031/7068

A61P 035/00 Antineoplastic agents

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/434,441 19.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003287833

8 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287834-USE OF AGLYCON PROTOPANAXADIOL IN CANCER THERAPY

2003287832-SEALING MEMBRANE ELECTRODE ASSEMBLIES FOR ELECTROCHEMICAL FUEL CELLS